Bmi-1 regulates epithelial-to-mesenchymal transition to promote migration and invasion of breast cancer cells

Int J Clin Exp Pathol. 2014 May 15;7(6):3057-64. eCollection 2014.

Abstract

Breast cancer is a highly invasive and metastatic disease. Recent studies report that breast cancer cells that have undergo epithelial-to-mesenchymal transition (EMT) obtain malignant characteristic, however, the molecular mechanism underlying this transition are poorly understood. Here, we found that over-expression associated with the process of breast cancer and that high B-cell-specific moloney murine leukemia virus insertion site 1 (Bmi-1) levels predict shorter survival of breast cancer patients. We demonstrate that Bmi-1 regulates EMT and the migration of breast cancer cells. RNA interference-mediated knockdown Bmi-1 expression restored E-cadherin expression and cell-cell junction formation in breast cancer cells, suppressing cell migration and invasion. In contrast, the over-expression of Bmi-1 decreased the expression of the epithelial mark (E-cadherin) but increased the mesenchymal makers (N-cadherin and vimentin) in breast cancer cells.

Keywords: Bmi-1; EMT; breast cancer; invasion; migration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / pathology*
  • Cell Line, Tumor
  • Cell Movement / physiology
  • Cell Separation
  • Disease Progression
  • Epithelial-Mesenchymal Transition / physiology*
  • Female
  • Flow Cytometry
  • Gene Knockdown Techniques
  • Humans
  • Immunoblotting
  • Neoplasm Invasiveness / pathology
  • Polycomb Repressive Complex 1 / metabolism*
  • RNA, Small Interfering
  • Real-Time Polymerase Chain Reaction
  • Tissue Array Analysis
  • Transfection

Substances

  • BMI1 protein, human
  • RNA, Small Interfering
  • Polycomb Repressive Complex 1